Skip to main content

International Journal of Hematology

Ausgabe 2/2014

Inhalt (15 Artikel)

Images in Hematology

Small lymphocytic lymphoma presenting as bulky renal incidentaloma

Kazuharu Kamachi, Kensuke Kojima, Aki Nishijima, Morishige Takeshita, Toshihiko Ando, Shinya Kimura

Images in Hematology

Relapse of acute megakaryocytic leukemia as hepatic myeloid sarcoma after allogeneic haploidentical hematopoietic stem cell transplantation

Toshihiko Imamura, Yoshihiro Nitta, Mitsuru Miyachi, Hiroyuki Ishida, Masafumi Ito, Hajime Hosoi

Original Article

No major role for the transcription factor NF-κB in bone marrow function during peritonitis in the mouse

Eirunn Knudsen, Harald Carlsen, Arne Bøyum, Haakon Breien Benestad, Per Ole Iversen

Original Article

Telephone versus office-based management of warfarin: impact on international normalized ratios and outcomes

Laura G. Stoudenmire, Christina E. DeRemer, Hazem Elewa

Original Article

Diagnosis of overt disseminated intravascular coagulation in critically Ill adults by Sonoclot coagulation analysis

Peng Wan, Hua-Sheng Tong, Xing-Qin Zhang, Peng-Kai Duan, You-Qing Tang, Lei Su

Original Article

Prognostic discrimination for early chronic phase chronic myeloid leukemia in imatinib era: comparison of Sokal, Euro, and EUTOS scores in Korean population

Seung-Ah Yahng, Eun-Jung Jang, Soo-Young Choi, Sung-Eun Lee, Soo-Hyun Kim, Dong-Wook Kim

Original Article

Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients

Soo-Jeong Kim, June-Won Cheong, Dae-Young Kim, Je-Hwan Lee, Kyoo-Hyung Lee, Yeo-Kyeoung Kim, Hyeong-Joon Kim, Ik-Chan Song, Deog-Yeon Jo, Jeong-Ok Lee, Soo-Mee Bang, Jinny Park, Jae Hoon Lee, Won-Sik Lee, Young-Don Joo, Chi Hoon Maeng, Hwi-Joong Yoon, Na-Ri Lee, Jae-Yong Kwak, Kyoung Ha Kim, Jong-Ho Won, Bo Ram Han, Dae Young Zang, Joon Ho Moon, Sang Kyun Sohn, Sung Hwa Bae, Hun Mo Ryoo, Sung-Yong Kim, Mark Hong Lee, Yoo Hong Min

Original Article

Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma

Kotaro Miyao, Reona Sakemura, Kanae Imai, Toshiyasu Sakai, Natsuko Tsushita, Tomonori Kato, Keiko Niimi, Yoshitaka Ono, Masashi Sawa

Original Article

Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients

Shuichiro Takashima, Toshihiro Miyamoto, Masanori Kadowaki, Yoshikiyo Ito, Takatoshi Aoki, Ken Takase, Takahiro Shima, Goichi Yoshimoto, Koji Kato, Tsuyoshi Muta, Motoaki Shiratsuchi, Katsuto Takenaka, Hiromi Iwasaki, Takanori Teshima, Tomohiko Kamimura, Koichi Akashi

Original Article

Homing of cytokine-induced killer cells during the treatment of acute promyelocytic leukemia

Hong Wang, Fenglin Cao, Jinmei Li, Yong Li, Xiuhua Liu, Lifan Wang, Zhiyu Liu, Yang Li, Hui Zhao, Jin Zhou

Original Article

Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocol

Hideki Nakayama, Ken Tabuchi, Akio Tawa, Ichiro Tsukimoto, Masahiro Tsuchida, Akira Morimoto, Hiromasa Yabe, Keizo Horibe, Ryoji Hanada, Masue Imaizumi, Yasuhide Hayashi, Kazuko Hamamoto, Ryoji Kobayashi, Kazuko Kudo, Akira Shimada, Takako Miyamura, Hiroshi Moritake, Daisuke Tomizawa, Takashi Taga, Souichi Adachi

Original Article

Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children’s Cancer Study Group (TCCSG) clinical trials

Motohiro Kato, Atsushi Manabe, Katsuyoshi Koh, Takeshi Inukai, Nobutaka Kiyokawa, Takashi Fukushima, Hiroaki Goto, Daisuke Hasegawa, Chitose Ogawa, Kazutoshi Koike, Setsuo Ota, Yasushi Noguchi, Akira Kikuchi, Masahiro Tsuchida, Akira Ohara

Original Article

Features of Epstein-Barr virus reactivation after allogeneic hematopoietic cell transplantation in Korean children living in an area of high seroprevalence against Epstein-Barr virus

Seung Beom Han, E Young Bae, Jae Wook Lee, Pil Sang Jang, Dong-Gun Lee, Nack-Gyun Chung, Dae Chul Jeong, Bin Cho, Soon Ju Lee, Jin Han Kang, Hack-Ki Kim

Case Report

A complex genomic abnormality found in a patient with antithrombin deficiency and autoimmune disease-like symptoms

Io Kato, Yuki Takagi, Yumi Ando, Yuki Nakamura, Moe Murata, Akira Takagi, Takashi Murate, Tadashi Matsushita, Tadaaki Nakashima, Tetsuhito Kojima

Case Report

Serial monitoring of Mucorales DNA load in serum samples of a patient with disseminated mucormycosis after allogeneic bone marrow transplantation

Tomonari Shigemura, Yozo Nakazawa, Kazuyuki Matsuda, Kenji Sano, Takashi Yaguchi, Mitsuo Motobayashi, Shoji Saito, Shunsuke Noda, Norimoto Kobayashi, Kazunaga Agematsu, Takayuki Honda, Kenichi Koike

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.